Apr 11, 2017 12:00:00 AM

Initiation of Coverage by Independent Investment Research

MedTech company Proteomics International is pleased to advise that Independent Investment Research (IIR) has initiated coverage on PILL.

2017

Proteomics International Laboratories Ltd is pleased to announce that it has closed its IPO after...

Proteomics International has contracted French immunoassay specialist Biotem to manufacture test...

Wholesale Investor is a leading platform for professional and international investors covering...

Related posts